title: Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation.
authors.affiliation: Department of Pathology, University of Pittsburgh, School of Medicine, Pennsylvania.
authors.forename: R
authors.initials: R
authors.lastname: Mañez
authors.forename: L T
authors.initials: LT
authors.lastname: White
authors.forename: S
authors.initials: S
authors.lastname: Kusne
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: R J
authors.initials: RJ
authors.lastname: Duquesnoy
mesh_terms: D000328:Adult; D003586:Cytomegalovirus Infections / Q000150:complications*; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D006684:HLA-DR Antigens / Q000276:immunology*; D006505:Hepatitis / Q000150:complications* / Q000382:microbiology; D006650:Histocompatibility Testing; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D014019:Tissue Donors
chemical_list: D006684:HLA-DR Antigens; D016853:Muromonab-CD3; D016559:Tacrolimus